Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2012
10/04/2012US20120252759 Thiazole derivatives for the treatment of diseases such as cancer
10/04/2012US20120252744 Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
10/04/2012US20120252743 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252730 Platelet aggregation inhibitors
10/04/2012US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
10/04/2012US20120252722 Metal-binding therapeutic peptides
10/04/2012US20120252719 Water soluble membrane proteins and methods for the preparation and use thereof
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251634 Traditional chinese drug comprising danshen extracts and sanqi extracts and use thereof
10/04/2012US20120251629 Methods of treatment and screening assays for hif-1alpha regulation
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251584 Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251549 Complement inhibitors and uses thereof
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251539 Methods and Compositions for the Treatment of Immune Disorders
10/04/2012US20120251525 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/04/2012US20120251513 Antigen Specific Tolerogenic Antigen Presenting Cells and Related Uses Compositions, Methods and Systems
10/04/2012US20120251508 Cytocompatible alginate gels
10/04/2012US20120251507 Compositions for preventing cardiac arrhythmia
10/04/2012US20120251498 Gene Delivery to Organs
10/04/2012US20120251495 Pterin based therapies for inflammatory conditions
10/04/2012US20120251486 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
10/04/2012US20120251483 Infarction Treatment Compositions and Methods
10/04/2012US20120251482 Use for improving 5-ht function and enos expression of kmups amine salts
10/04/2012DE102011015567A1 Dosage forms, useful e.g. for the acute treatment of stress-induced pathologies in the central nervous system and cardiovascular system, comprise beta blockers, which are in the form of liquid aerosols
10/04/2012CA2831929A1 Pyrazolo pyrimidine derivatives
10/04/2012CA2831771A1 Polyamide compound and pharmaceutical composition for treating mitochondrial genetic diseases
10/04/2012CA2831493A1 Thieno [2, 3 -d]pyrimidine derivatives and their use to treat arrhythmia
10/04/2012CA2831015A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012CA2830965A1 Benzoic acid salt of otamixaban
10/04/2012CA2830664A1 Pegylated human hdl particle and process for production thereof
10/04/2012CA2830447A1 New azaspirodecanone compounds as hsl inhibitors
10/03/2012EP2505660A1 Method for screening of therapeutic agent for hyperlipemia
10/03/2012EP2505202A1 D-myo-inositol 3,4,5,6-tetrakisphosphate to modulate thrombin/antithrombin activity by heparin binding
10/03/2012EP2505198A1 Compounds for use as therapeutic agents affecting p53 expression and/or activity
10/03/2012EP2505196A1 Antithrombotic agent
10/03/2012EP2504434A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation
10/03/2012EP2504337A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
10/03/2012EP2504331A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
10/03/2012EP2504004A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
10/03/2012EP2504003A1 Nitroxyl donors for the treatment of pulmonary hypertension
10/03/2012CN1972714B Methods of treating autoimmune and inflammatory diseases
10/03/2012CN1658898B Orodispersible pharmaceutical composition comprising perindopril
10/03/2012CN102712641A MK2 inhibitors
10/03/2012CN102712638A New phenylhydrazone derivatives and their use as pharmaceuticals
10/03/2012CN102712626A Piperazine compound having a PGDS inhibitory effect
10/03/2012CN102712589A Aryl-pyridine derivatives as aldosterone synthase inhibitors
10/03/2012CN102712577A Substituted 3-phenylpropionic acids and the use thereof
10/03/2012CN102711797A Compositions and methods for treatment of aortic fibrosis
10/03/2012CN102711784A Composition and method for improving vascular health
10/03/2012CN102711781A A novel boswellia low polar gum resin extract and its synergistic compositions
10/03/2012CN102711780A Preparation comprising amino acids and plants and its activity in alcohol detoxification
10/03/2012CN102711768A Compositions and methods for the prevention and treatment of heart failure
10/03/2012CN102711763A Pharmaceutical composition for oral administration
10/03/2012CN102711762A Solid pharmaceutical composition for oral administration
10/03/2012CN102711756A Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
10/03/2012CN102703389A Poxviral oncolytic vectors
10/03/2012CN102703388A Anti-human mCRP (monomeric C-reaction protein) monoclonal antibody, hybridoma cell lines and kit
10/03/2012CN102703382A Technique for heart disease external differentiation therapy by utilizing stem cells of masticatory muscles and orbicularis oculi muscles
10/03/2012CN102703296A Lycium ruthenicum health-care wine
10/03/2012CN102702310A Marine peptides compounds and application of marine peptides compounds to preparation of angiogenesis medicines
10/03/2012CN102702303A Tanshinone derivative, medicinal composition thereof and application of tanshinone derivative to pharmacy
10/03/2012CN102702298A Glycyrrhetinic acid derivative and preparation method and medical application thereof
10/03/2012CN102702288A Method for glycosylation of flavonoid compounds
10/03/2012CN102702210A Application of phthalocyanine metal complex containing piperazine ethyoxyl modified groups
10/03/2012CN102702200A (6RS)-5-methyl tetrahydrofolate calcium salt crystal form and preparation process thereof
10/03/2012CN102702171A Process for producing acid adduct salt of polyacidic base compound
10/03/2012CN102702164A Human ATP-binding cassette transporter A1 activity regulator screening model and application thereof
10/03/2012CN102702156A Pinocembrin alpha crystal form and preparation method and use in disease treatment thereof
10/03/2012CN102702155A Scutellarin aglycone methylate product based on in-vivo metabolic mechanism as well as preparation method and application of scutellarin aglycone methylate product
10/03/2012CN102702119A Pharmaceutical combinations of an angiotensin receptor antagonist and an NEP inhibitor
10/03/2012CN102702118A Valsartan organic pharmaceutical co-crystal and preparation method thereof
10/03/2012CN102702092A Eutectic of two curcumin organic medicaments and preparation method thereof
10/03/2012CN102702070A Solid form containing (+)-2-[1-(3-oxethyl-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, composition and application thereof
10/03/2012CN102702068A 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative, and application of 3-pyrrolo-cyclohexylidene-2-dihydroindolone derivative
10/03/2012CN102702061A Stachydrine hydrochloride compound and medicinal composition containing stachydrine hydrochloride compound
10/03/2012CN102702041A Agomelatine benzenesulfonic acid compound and preparation method thereof
10/03/2012CN102702013A Nuclear receptor binding agents
10/03/2012CN102702008A Agomelatine sulfuric acid composition and preparation method thereof
10/03/2012CN102698287A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
10/03/2012CN102698284A Coenzyme Q10/amylose inclusion compound and preparation method thereof
10/03/2012CN102698283A Baicalein clathrate and preparation method thereof
10/03/2012CN102698253A Adenosine disodium triphosphate composition
10/03/2012CN102698246A Antihypertensive drug of enalapril and safflower oil nanoemulsion
10/03/2012CN102698245A Antihypertensive drug of quinapril hydrochloride and rose oil nanoemulsion
10/03/2012CN102698238A Group of capsules for nourishing kidney and tonifying yang
10/03/2012CN102698234A Tablet for activating yang, removing stasis, promoting circulation of qi, and widening chest
10/03/2012CN102698231A Tablets for tonifying qi and warming channels to relieve rheumatism
10/03/2012CN102698222A Drug for treating bradycardia and preparation method of drug
10/03/2012CN102698218A Traditional Chinese medicine prescription for internal use to treat high blood pressure
10/03/2012CN102698217A Traditional Chinese medicine preparation for internal use to treat high blood pressure
10/03/2012CN102698201A Chinese medicine for treating varicocele
10/03/2012CN102698192A Traditional Chinese medicament for treating dilated cardiomyopathy
10/03/2012CN102698186A Traditional Chinese medicinal composition for treating yin-deficiency bipolar type systolic and diastolic hypertension
10/03/2012CN102698137A Composition with blood pressure reducing function and preparation method of same
10/03/2012CN102698135A Traditional Chinese medicine composition for treating hypertension, hyperglycemia and hyperlipidemia, and application thereof
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 1595